Etanidazole
N/A
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameEtanidazole
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSri InternationalNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Cancer InstituteSri InternationalBristol-Myers Squibb Company +[4]
Active IndicationsN/A
Inactive Indications